scispace - formally typeset
J

John D. Martin

Researcher at University of Tokyo

Publications -  63
Citations -  10944

John D. Martin is an academic researcher from University of Tokyo. The author has contributed to research in topics: Tumor microenvironment & Medicine. The author has an hindex of 32, co-authored 52 publications receiving 8812 citations. Previous affiliations of John D. Martin include Massachusetts Institute of Technology & Harvard University.

Papers
More filters
Journal ArticleDOI

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study.

TL;DR: New MRI neuroimaging techniques are used to derive volume measurements and three-dimensional reconstructions of temporal-lobe structures in vivo in 15 right-handed men with chronic schizophrenia and 15 matched controls to discover the degree of thought disorder is related to the size of the reduction in volume of the left posterior superior temporal gyrus.
Journal ArticleDOI

Multistage nanoparticle delivery system for deep penetration into tumor tissue

TL;DR: In vivo circulationHalf-life and intratumoral diffusion measurements indicate that the multistage nanoparticles exhibited both the long circulation half-life necessary for the EPR effect and the deep tumor penetration required for delivery into the tumor's dense collagen matrix.
Journal ArticleDOI

Normalization of Tumour Blood Vessels Improves the Delivery of Nanomedicines in a Size-Dependent Manner

TL;DR: In this paper, the authors showed that repairing the abnormal vessels in mammary tumours, by blocking vascular endothelial growth factor receptor-2, improves the delivery of smaller nanoparticles (diameter, 12 nm) while hindering delivery of larger nanoparticles, and further suggest that smaller (∼12 nm) nanomedicines are ideal for cancer therapy due to their superior tumour penetration.
Journal ArticleDOI

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

TL;DR: It is demonstrated that targeting tumor vasculature with lower vascular-normalizing doses, but not high antivascular/antiangiogenic doses, of an anti-VEGF receptor 2 (VEGFR2) antibody results in a more homogeneous distribution of functional tumor vessels.
Journal ArticleDOI

The role of mechanical forces in tumor growth and therapy.

TL;DR: Shear stresses exerted by flowing blood and interstitial fluid modulate the behavior of cancer and a variety of host cells, and taming these physical forces can improve therapeutic outcomes in many cancers.